Plasma Arginine Vasopressin in Hyponatremic Patients with Heart Failure
To the Editor: We offer the following comments in reference to the paper by Szatalowicz et al. 1 in the July 30 issue, reporting detectable arginine vasopressin (AVP) levels in some hyponatremic patients with heart failure. Although 3.04±0.84 pg per milliliter was the mean value for AVP in the group...
Gespeichert in:
Veröffentlicht in: | The New England journal of medicine 1981-12, Vol.305 (24), p.1470-1472 |
---|---|
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1472 |
---|---|
container_issue | 24 |
container_start_page | 1470 |
container_title | The New England journal of medicine |
container_volume | 305 |
description | To the Editor:
We offer the following comments in reference to the paper by Szatalowicz et al.
1
in the July 30 issue, reporting detectable arginine vasopressin (AVP) levels in some hyponatremic patients with heart failure. Although 3.04±0.84 pg per milliliter was the mean value for AVP in the group with "detectable" levels, this number is somewhat misleading because of the presence of several very high values. Two thirds of the levels were actually below 2.0 pg per milliliter, and half of those were under 1.0 pg per milliliter. Thus, in most subjects, even in this group, AVP was nearly completely . . . |
doi_str_mv | 10.1056/NEJM198112103052412 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73747464</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73747464</sourcerecordid><originalsourceid>FETCH-LOGICAL-c336t-5c46b4a9a7991e492d6f14cd18074f63ca022a3510d3904fbd2e6e68e7c848303</originalsourceid><addsrcrecordid>eNp9kE1LwzAYx4Moc04_gQg9eZHqkyZNmuMYe1Gm7qBeS5Y-1YymnUmL7Ntb2fAkPvzhOfxfDj9CLincUkjF3dP04ZGqjNKEAoM04TQ5IkOaMhZzDuKYDAGSLOZSsVNyFsIG-qNcDchAMoBMyCGZryodnI7G_t3WtsboTYdm6zEEW0e9FrttU-vWo7MmWunWYt2G6Mu2H9ECtW-jmbZV5_GcnJS6Cnhx-CPyOpu-TBbx8nl-PxkvY8OYaOPUcLHmWmmpFEWukkKUlJuCZiB5KZjRkCSapRQKpoCX6yJBgSJDaTKeMWAjcr3f3frms8PQ5s4Gg1Wla2y6kEsmueSC90G2DxrfhOCxzLfeOu13OYX8B1_-B76-dXWY79YOi9_OgVfv3-x950Je48b9u_YNpQF10Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73747464</pqid></control><display><type>article</type><title>Plasma Arginine Vasopressin in Hyponatremic Patients with Heart Failure</title><source>MEDLINE</source><source>ProQuest Central UK/Ireland</source><description>To the Editor:
We offer the following comments in reference to the paper by Szatalowicz et al.
1
in the July 30 issue, reporting detectable arginine vasopressin (AVP) levels in some hyponatremic patients with heart failure. Although 3.04±0.84 pg per milliliter was the mean value for AVP in the group with "detectable" levels, this number is somewhat misleading because of the presence of several very high values. Two thirds of the levels were actually below 2.0 pg per milliliter, and half of those were under 1.0 pg per milliliter. Thus, in most subjects, even in this group, AVP was nearly completely . . .</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJM198112103052412</identifier><identifier>PMID: 7300867</identifier><language>eng</language><publisher>United States: Massachusetts Medical Society</publisher><subject>Animals ; Arginine Vasopressin - blood ; Dogs ; Heart Failure - blood ; Heart Failure - complications ; Humans ; Hyponatremia - blood ; Hyponatremia - etiology</subject><ispartof>The New England journal of medicine, 1981-12, Vol.305 (24), p.1470-1472</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c336t-5c46b4a9a7991e492d6f14cd18074f63ca022a3510d3904fbd2e6e68e7c848303</citedby><cites>FETCH-LOGICAL-c336t-5c46b4a9a7991e492d6f14cd18074f63ca022a3510d3904fbd2e6e68e7c848303</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908,64368</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7300867$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><title>Plasma Arginine Vasopressin in Hyponatremic Patients with Heart Failure</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>To the Editor:
We offer the following comments in reference to the paper by Szatalowicz et al.
1
in the July 30 issue, reporting detectable arginine vasopressin (AVP) levels in some hyponatremic patients with heart failure. Although 3.04±0.84 pg per milliliter was the mean value for AVP in the group with "detectable" levels, this number is somewhat misleading because of the presence of several very high values. Two thirds of the levels were actually below 2.0 pg per milliliter, and half of those were under 1.0 pg per milliliter. Thus, in most subjects, even in this group, AVP was nearly completely . . .</description><subject>Animals</subject><subject>Arginine Vasopressin - blood</subject><subject>Dogs</subject><subject>Heart Failure - blood</subject><subject>Heart Failure - complications</subject><subject>Humans</subject><subject>Hyponatremia - blood</subject><subject>Hyponatremia - etiology</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1981</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LwzAYx4Moc04_gQg9eZHqkyZNmuMYe1Gm7qBeS5Y-1YymnUmL7Ntb2fAkPvzhOfxfDj9CLincUkjF3dP04ZGqjNKEAoM04TQ5IkOaMhZzDuKYDAGSLOZSsVNyFsIG-qNcDchAMoBMyCGZryodnI7G_t3WtsboTYdm6zEEW0e9FrttU-vWo7MmWunWYt2G6Mu2H9ECtW-jmbZV5_GcnJS6Cnhx-CPyOpu-TBbx8nl-PxkvY8OYaOPUcLHmWmmpFEWukkKUlJuCZiB5KZjRkCSapRQKpoCX6yJBgSJDaTKeMWAjcr3f3frms8PQ5s4Gg1Wla2y6kEsmueSC90G2DxrfhOCxzLfeOu13OYX8B1_-B76-dXWY79YOi9_OgVfv3-x950Je48b9u_YNpQF10Q</recordid><startdate>19811210</startdate><enddate>19811210</enddate><general>Massachusetts Medical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19811210</creationdate><title>Plasma Arginine Vasopressin in Hyponatremic Patients with Heart Failure</title></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c336t-5c46b4a9a7991e492d6f14cd18074f63ca022a3510d3904fbd2e6e68e7c848303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1981</creationdate><topic>Animals</topic><topic>Arginine Vasopressin - blood</topic><topic>Dogs</topic><topic>Heart Failure - blood</topic><topic>Heart Failure - complications</topic><topic>Humans</topic><topic>Hyponatremia - blood</topic><topic>Hyponatremia - etiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Plasma Arginine Vasopressin in Hyponatremic Patients with Heart Failure</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>1981-12-10</date><risdate>1981</risdate><volume>305</volume><issue>24</issue><spage>1470</spage><epage>1472</epage><pages>1470-1472</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><abstract>To the Editor:
We offer the following comments in reference to the paper by Szatalowicz et al.
1
in the July 30 issue, reporting detectable arginine vasopressin (AVP) levels in some hyponatremic patients with heart failure. Although 3.04±0.84 pg per milliliter was the mean value for AVP in the group with "detectable" levels, this number is somewhat misleading because of the presence of several very high values. Two thirds of the levels were actually below 2.0 pg per milliliter, and half of those were under 1.0 pg per milliliter. Thus, in most subjects, even in this group, AVP was nearly completely . . .</abstract><cop>United States</cop><pub>Massachusetts Medical Society</pub><pmid>7300867</pmid><doi>10.1056/NEJM198112103052412</doi><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0028-4793 |
ispartof | The New England journal of medicine, 1981-12, Vol.305 (24), p.1470-1472 |
issn | 0028-4793 1533-4406 |
language | eng |
recordid | cdi_proquest_miscellaneous_73747464 |
source | MEDLINE; ProQuest Central UK/Ireland |
subjects | Animals Arginine Vasopressin - blood Dogs Heart Failure - blood Heart Failure - complications Humans Hyponatremia - blood Hyponatremia - etiology |
title | Plasma Arginine Vasopressin in Hyponatremic Patients with Heart Failure |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T13%3A11%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Plasma%20Arginine%20Vasopressin%20in%20Hyponatremic%20Patients%20with%20Heart%20Failure&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.date=1981-12-10&rft.volume=305&rft.issue=24&rft.spage=1470&rft.epage=1472&rft.pages=1470-1472&rft.issn=0028-4793&rft.eissn=1533-4406&rft_id=info:doi/10.1056/NEJM198112103052412&rft_dat=%3Cproquest_cross%3E73747464%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73747464&rft_id=info:pmid/7300867&rfr_iscdi=true |